TP53 and cancer: Moreover, TP53 mutations are frequently identified in non-tumor cells in 50% of the cases of pediatric low-hypodiploid B-ALL, implying that these cases may be a manifestation of Li–Fraumeni syndrome or other germline TP53 cancer-predisposing mutations [44].